Arterioportal Shunt

 Wedge-shaped area of hyperattenuation with straight margins seen during arterial phase of CECT or MR


image Becomes isodense to hepatic parenchyma during portal venous phase of CECT or gadolinium-enhanced MR


• Peripherally within hepatic segment or lobe

• Usually ≤ 1.5 cm (e.g., cirrhotic arterioportal [AP] shunts)
image Larger in some cases of post-biopsy AP shunts

image Early enhancement of peripheral portal vein (PV) branches prior to visualization of main PV




TOP DIFFERENTIAL DIAGNOSES




• Hypervascular liver mass (e.g., hepatocellular carcinoma [HCC])
image Usually round or oval, not wedge-shaped

image Usually shows washout on venous phase

• Hemangioma
image Attenuation tracks blood pool on all phases

• Focal sparing with fatty liver
image Not really hypervascular foci

image Relatively high-attenuation areas of “normal” liver surrounded by low-attenuation fatty liver


PATHOLOGY




• Small AP shunts are not amenable to biopsy
image Too small; invisible on NECT and US


DIAGNOSTIC CHECKLIST




• Small (< 1.5 cm) AP shunts are common in cirrhosis
image If unassociated with focal lesion on MR, it is probably insignificant

image Follow-up in ∼ 6 months is indicated and adequate

• Do not mistake multiple small AP shunts for multifocal HCC

image
(Left) Seen only on the arterial set of images are multiple peripheral, wedge-shaped, hyperenhancing foci image in this 60-year-old man with cirrhosis due to chronic viral hepatitis.


image
(Right) Axial arterial phase CECT in the same patient shows additional peripheral, wedge-shaped, hypervascular foci image. Also note the large, “corkscrew” hepatic arterial branch image, a typical feature of cirrhosis. The liver has a cirrhotic morphology with wide fissures.

image
(Left) Axial portal venous phase CECT in the same patient shows none of the peripheral hypervascular lesions, which have become isodense to liver.


image
(Right) Axial delayed phase CECT shows no washout or other evidence of the focal peripheral lesions seen on arterial phase. AP shunts are common within the cirrhotic liver. Imaging features that favor AP shunt over HCC include peripheral, subcapsular location, small size, wedge shape, and no corresponding lesion on venous or delayed phase imaging.


TERMINOLOGY


Abbreviations




• Arterioportal (AP) shunt


Definitions




• Communication between a branch of hepatic artery and portal venous system


IMAGING


General Features




• Best diagnostic clue
image Nodular or wedge-shaped area of hyperattenuation with straight margins seen during arterial phase of CECT or gadolinium-enhanced MR

image Becomes isodense to hepatic parenchyma during portal venous phase of CECT or gadolinium-enhanced MR

• Location
image Peripherally within hepatic segment or lobe

• Size
image Usually ≤ 1.5 cm (e.g., cirrhotic AP shunts)
– Larger in some cases of post-biopsy AP shunts

– Transient hepatic attenuation difference (THAD) and transient hepatic intensity difference (THID) can be much larger
image Can involve entire hepatic segment or lobe

• Morphology
image Wedge-shaped with straight margins


Imaging Recommendations




• Best imaging tool
image Multiphasic CECT or gadolinium-enhanced MR

• Protocol advice
image Arterial phase acquisition of CECT or MR at 25-35 seconds after injection
– Followed by venous phase (60-70 seconds) and delayed phase (∼ 120 seconds)


CT Findings




• Arterial phase imaging
image Early enhancement of peripheral portal vein (PV) branches prior to visualization of main PV

image Peripheral wedge-shaped area of increased attenuation with straight edges within affected segment or lobe
– Hyperdense areas on arterial phase imaging

• Portal venous and delayed phase imaging
image Area of previously increased attenuation equilibrates, becomes nearly isodense with rest of liver

image Cause of larger AP shunt (e.g., PV thrombosis, hepatic mass) may be more visible during portal venous phase


MR Findings




• T1WI
image T1WI and T2WI usually normal for nontumoral causes of AP shunts

• T2WI
image Rarely slight increase in T2 signal in affected lobe or segment of nontumoral shunts

image Underlying mass may cause abnormal T2 signal with AP shunts related to hepatic masses or tumors

• Dynamic gadolinium-enhanced MR
image Arterial phase imaging (25-35 seconds after injection)
– Wedge-shaped area of increased signal intensity in segment or lobe of shunt

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Nov 16, 2016 | Posted by in GASTROINTESTINAL IMAGING | Comments Off on Arterioportal Shunt

Full access? Get Clinical Tree

Get Clinical Tree app for offline access